ALS Blood Biomarkers Could Lead to Better Management of Disease
A new study identifies the most effective blood biomarkers for diagnosing and predicting the progression of ALS.
A new study identifies the most effective blood biomarkers for diagnosing and predicting the progression of ALS.
A Michigan Medicine-led study found that living in a disadvantaged community may significantly shorten ALS survival, highlighting the impact of socioeconomic factors on disease progression.
Innovations in rehabilitation techniques—from telehealth to advanced neurotechnology—are enhancing recovery outcomes for stroke survivors.
LimFlow’s FDA approval follows study results which found that the therapy enabled most patients treated to keep their leg and experience wound healing.
Researchers have developed a python-teeth-inspired device for rotator cuff repairs that effectively grasps soft tissues without tearing.
A large-scale study of military veterans suggests a possible link between hearing loss and increased risk of Parkinson’s disease.
A four-year distribution agreement for the Provizio SEM Scanner, used to prevent pressure injuries, has not been extended.
The patent describes the company’s formula of precision-targeted vibration therapy to reduce the loss of bone density and strength in the lumbar spine in postmenopausal women.
The company says the clearance is supported by safety and effectiveness data of the exoskeleton in patients with spinal cord injuries at levels T5 to L5 and has been evaluated in more than 500 patients.